Cyfuse Biomedical K.K. (4892.T)

JPY 994.0

(-0.1%)

Total Liabilities Summary of Cyfuse Biomedical K.K.

  • Cyfuse Biomedical K.K.'s latest annual total liabilities in 2023 was 1.01 Billion JPY , down -3.27% from previous year.
  • Cyfuse Biomedical K.K.'s latest quarterly total liabilities in 2024 Q1 was 908.55 Million JPY , down -10.16% from previous quarter.
  • Cyfuse Biomedical K.K. reported annual total liabilities of 1.04 Billion JPY in 2022, up 40.13% from previous year.
  • Cyfuse Biomedical K.K. reported annual total liabilities of 746.11 Million JPY in 2021, up 15.36% from previous year.
  • Cyfuse Biomedical K.K. reported quarterly total liabilities of 913.71 Million JPY for 2024 Q2, up 0.57% from previous quarter.
  • Cyfuse Biomedical K.K. reported quarterly total liabilities of 930.96 Million JPY for 2023 Q3, down -4.59% from previous quarter.

Annual Total Liabilities Chart of Cyfuse Biomedical K.K. (2023 - 2020)

Historical Annual Total Liabilities of Cyfuse Biomedical K.K. (2023 - 2020)

Year Total Liabilities Total Liabilities Growth
2023 1.01 Billion JPY -3.27%
2022 1.04 Billion JPY 40.13%
2021 746.11 Million JPY 15.36%
2020 646.75 Million JPY 0.0%

Peer Total Liabilities Comparison of Cyfuse Biomedical K.K.

Name Total Liabilities Total Liabilities Difference
Pharma Foods International Co., Ltd. 24.98 Billion JPY 95.953%
Takeda Pharmaceutical Company Limited 7834.78 Billion JPY 99.987%
Sumitomo Pharma Co., Ltd. 751.37 Billion JPY 99.865%
Shionogi & Co., Ltd. 164.35 Billion JPY 99.385%
Wakamoto Pharmaceutical Co.,Ltd. 3.39 Billion JPY 70.211%
Nippon Shinyaku Co., Ltd. 42.86 Billion JPY 97.641%
Kaken Pharmaceutical Co., Ltd. 27.86 Billion JPY 96.371%
Eisai Co., Ltd. 494.82 Billion JPY 99.796%
Morishita Jintan Co., Ltd. 5.04 Billion JPY 79.934%
Hisamitsu Pharmaceutical Co., Inc. 61.69 Billion JPY 98.361%
Mochida Pharmaceutical Co., Ltd. 30.83 Billion JPY 96.72%
Fuso Pharmaceutical Industries,Ltd. 39.79 Billion JPY 97.459%
Nippon Chemiphar Co., Ltd. 31.08 Billion JPY 96.746%
Tsumura & Co. 132.88 Billion JPY 99.239%
Kissei Pharmaceutical Co., Ltd. 39.79 Billion JPY 97.458%
Torii Pharmaceutical Co., Ltd. 13.29 Billion JPY 92.394%
Towa Pharmaceutical Co., Ltd. 274.75 Billion JPY 99.632%
Fuji Pharma Co., Ltd. 44.15 Billion JPY 97.71%
Zeria Pharmaceutical Co., Ltd. 70.7 Billion JPY 98.57%
KYORIN Holdings, Inc. 46.89 Billion JPY 97.843%
Taiko Pharmaceutical Co.,Ltd. 7 Billion JPY 85.558%
Daito Pharmaceutical Co.,Ltd. 25.43 Billion JPY 96.024%
SymBio Pharmaceuticals Limited 8.14 Billion JPY 87.579%
MedRx Co., Ltd 129 Million JPY -683.984%
Mizuho Medy Co.,Ltd. 3.27 Billion JPY 69.096%
Solasia Pharma K.K. 673 Million JPY -50.273%
Modalis Therapeutics Corporation 645.5 Million JPY -56.675%
ASKA Pharmaceutical Holdings Co.,Ltd. 31.38 Billion JPY 96.777%
Sawai Group Holdings Co., Ltd. 163.99 Billion JPY 99.383%
Toho Holdings Co., Ltd. 523.98 Billion JPY 99.807%
Koa Shoji Holdings Co.,Ltd. 6.95 Billion JPY 85.453%